Hybrid oligomers of Aβ and α-synuclein have been identified in the brains of patients with AD and DLB patients, as well as in amyloid precursor protein/α-synuclein transgenic mice, suggesting a direct interaction between the two [28]. This evidence concerns the gene APP and Alzheimer disease.